Archive: 14/12/2015
Expensive, exploratory research biopsies overused in early studies of new cancer drugs
For more than a decade, researchers studying the newest anticancer drugs have taken extra biopsies solely for the purpose of trying to understand the pharmacodynamics—what the drug does to the tumor—of a new anticancer ...
Dec 14, 2015
Continuous joint use of estrogen and progestin lowers risk of EC in postmenopausal women
Adding continuous progestin to estrogen has been shown to lower the risk of endometrial cancer in postmenopausal women according to a study published December 14 in the JNCI: Journal of the National Cancer Institute.
Dec 14, 2015
Learning on the job: Johns Hopkins Medicine Alliance for Patients
Academic medical centers that take on community partners to form accountable care organizations face a number of unexpected challenges, says Scott Berkowitz, M.D., M.B.A., medical director of accountable care for the Office ...
Dec 14, 2015
Scientists uncover process that could drive the majority of cancers
The gene p53 has been described as the "guardian of the genome" due to its prominent role in preventing genetic mutations. More than half of all cancers are thought to originate from p53 mutations or loss of function, and ...
Dec 14, 2015
Medication protects fertility and defense system during chemotherapy
While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several ...
Dec 14, 2015